Open AccessEffects of SGLT2 inhibitors on cardiovascular outcomes and mortality in type 2 diabetes
Author(s) -
Caiyan Zou,
Xuekui Liu,
Yiquan Sang,
Ben Wang,
Jun Liang
Publication year - 2019
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000018245
Subject(s) - medicine , dapagliflozin , empagliflozin , canagliflozin , type 2 diabetes , glycemic , diabetes mellitus , meta analysis , randomized controlled trial , myocardial infarction , cochrane library , stroke (engine) , adverse effect , insulin , endocrinology , mechanical engineering , engineering